Vaccine Information Statement (VIS) -- Haemophilus Influenzae Type b (Hib) Vaccine: What You Need to Know
This two-page Vaccine Information Statement (VIS) educates people about the vaccine for haemophilus influenzae type b (Hib) disease. Before the Hib vaccine, Hib disease was the leading cause of bacterial meningitis among children under 5 years old in the U.S. Hib disease can also affect adults with certain medical conditions. The VIS discusses Hib symptoms and transmission, who should receive the Hib vaccine, and dosage schedule. It identifies who should not get vaccinated, risks and side effects, and what to look for and what to do in the event of a serious allergic reaction. Contact information for the National Vaccine Injury Compensation Program (VICP) is provided, along with tips for how people can learn more about the Hib vaccine.
The English-language VIS was created by the Centers for Disease Control and Prevention (CDC) National Center for Immunization and Respiratory Diseases. The translations are provided by the Immunization Action Coalition (IAC) and its partner organizations.
A qualified translation company performed an independent review by a second translator, and a client advocate.